Guidance For Industry (GFI) #263 now requires some pharmaceutical products to require a prescription. Click here to learn more.

VISTA 3 VL5 SQ - Animal Health Express
VISTA 3 VL5 SQ - Animal Health Express

Merck Bovilis Vista 3 BL5 SQ

MRKVC160

Regular price
$17.50
Sale price
$17.50

*Free Shipping On Orders $50 Or More! (Excluding Cold And Hazardous Items)

Merck Bovilis Vista 3 VL5 SQ is for the vaccination of healthy cows and heifers prior to breeding in aid in the reduction of abortion due to IBR, BVD Type 1 & 2.

Safe for use in pregnant heifers and cows or calves nursing pregnant cows provided the cows and heifers in the herd are vaccinated prior tobreeding, within the previous 12 months, with any of the modified-live IBR and BVD containing vaccine(s) in this product line.

Merck Bovilis Vista3 VL5 SQ is for the vaccination of healthy cows and heifers prior to breeding as an aid in the reduction of abortion due to IBR; as an aid in the prevention of fetal infection, including persistently infected calves caused by BVD virus Type 1; and as an aid in the prevention of persistently infected calves caused by BVD virus Type 2.

Reproductive Duration of Immunity (DOI) has been demonstrated to be at least 217 days for IBR, at least 206 days for BVD (Type 1) and at least 112 days for BVD (Type 2). In addition, it can be used as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR) virus and bovine virus diarrhea (BVD) virus (Type 2); as an aid in the control of disease caused by bovine virus diarrhea (BVD) virus (Type 1), as an aid in reducing infertility (reproductive disease caused by Campylobacter fetus), and as an aid in preventing leptospirosis (caused by Leptospira canicola, L. grippotyphosa, L. hardjo - including the L. borgpetersenii serovar hardjo bovis, L. icterohaemorrhagiae, and L. pomona) and as an aid in prevention of urinary shedding of L. hardjo organisms.

Respiratory DOI has been demonstrated to be at least 182 days for IBR, and at least 206 days for BVD Type 1 and at least 200 days for BVD Type 2. Calves nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.

Safe for use in pregnant heifers and cows or calves nursing pregnant cows provided the cows and heifers in the herd are vaccinated prior tobreeding, within the previous 12 months, with any of the modified-live IBR and BVD containing vaccine(s) in this product line.

Dosage
2 mL administered subcutaneously 14 to 60 days prior to breeding. Annual revaccination is recommended.

Merck


Click here to read the product label